SCHEMBL4756311

SCHEMBL4756311

COc1ccc([N+]2(C3CCNCC3)CCCCC2)cc1-c1cnn2c(N)c(-c3cccc(Cl)c3)c(C)nc12

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RET P07949 6/20 0.47
KIF5B P33176 6/20 0.47
KDR P35968 5/20 0.47
ETV6 P41212 5/20 0.47
CCDC6 Q16204 4/20 0.47
FYN P06241 1/20 0.42
NPC1 O15118 7/20 0.41
MEN1 O00255 7/20 0.41
KMT2A Q03164 7/20 0.41
CASP3 P42574 2/20 0.41
SENP8 Q96LD8 2/20 0.41
SENP7 Q9BQF6 2/20 0.41
SENP6 Q9GZR1 2/20 0.41
RAB9A P51151 7/20 0.40
RXFP1 Q9HBX9 1/20 0.40
ABL1 P00519 1/20 0.39
LCK P06239 1/20 0.39
NPM1 P06748 1/20 0.39
CSF1R P07333 1/20 0.39
LYN P07948 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4173163 0.80 FYN (0.47) RETKIF5BKDRETV6CCDC6
SCHEMBL13905642 0.78 FYN (0.52) RETKIF5BKDRETV6CCDC6
SCHEMBL4757041 0.77 FYN (0.53) RETKIF5BKDRETV6CCDC6
SCHEMBL4162862 0.77 FYN (0.43) RETKIF5BKDRETV6CCDC6
SCHEMBL4180131 0.76 FYN (0.46) RETKIF5BKDRETV6CCDC6
SCHEMBL4177518 0.76 FYN (0.44) RETKIF5BKDRETV6CCDC6
SCHEMBL4180605 0.75 RET (0.56) RETKIF5BKDRETV6CCDC6
SCHEMBL4179850 0.75 FYN (0.71) RETKIF5BKDRETV6CCDC6
SCHEMBL4178858 0.75 FYN (0.57) RETKIF5BKDRETV6CCDC6
SCHEMBL4167171 0.75 FYN (0.44) RETKIF5BKDRETV6CCDC6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1993552-A2 USE OF PYRAZOLO[1,5A]PYRIMIDIN-7-YL AMINE DERIVATIVES IN THE TREATMENT OF NEUROLOGICAL DISORDERS Novartis AG (CH) 2008-11-26 EP disclosed
WO-2007103432-A9 USE OF PYRAZOLO[1,5A]PYRIMIDIN-7-YL AMINE DERIVATIVES IN THE TREATMENT OF NEUROLOGICAL DISORDERS NOVARTIS AG (CH) 2008-01-10 WO disclosed
WO-2007103432-A2 USE OF PYRAZOLO[1,5A]PYRIMIDIN-7-YL AMINE DERIVATIVES IN THE TREATMENT OF NEUROLOGICAL DISORDERS NOVARTIS AG (CH) 2007-09-13 WO disclosed